HAVCR2 and nasopharyngeal carcinoma: The inhibitory signatures on CD8+ T cells, including PD-1, HAVCR2 and LAG3 have been found up-regulated by EpCAM+HLA-DRHigh NPC cells via ligand-receptor interaction (50).